Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 4, 2018

View Archived Issues

Breathing control can be restored long after SCI

Gene therapy rewires brain in PD

Abrogating androgen axis of evil

FIT free lunch

Lilly opens phase II study of LY-3209590 for type 2 diabetes

Faron receives regulatory approval to initiate first-in-human MATINS study of Clevegen

Primary endpoint met in phase II study of tradipitant in patients with gastroparesis

Preclinical data support potential of CAP-1160 for treatment and prevention of cataracts

KIN-8193, a selective and potent HCK inhibitor, overcomes ibrutinib resistance in B-cell lymphoma

FDA clears Fate Therapeutics to begin clinical trial of iPSC-derived FT-500

Novel model of acute repetitive seizures in mice

Turnstone Biologics reveals vaccinia oncolytic viral immunotherapy platform

Bristol-Myers Squibb presents phase I results for BMS-986115

First-in-human phase I study reveals potent antitumor activity of AMG-420 against R/R MM

BenevolentAI Bio presents new orexin OX2 receptor antagonists

Nanjing Sanhome Pharmaceutical discloses FGFR-4 inhibitors

Bristol-Myers Squibb patents IDO1 inhibitors

Celon Pharma Sp zoo divulges JAK1 and JAK3 inhibitors

AstraZeneca synthesizes mutant KRAS inhibitors

NYX-2925 shows promising effects in patients with fibromyalgia

Progenics begins phase III trial of PyL imaging agent to detect prostate cancer

Chinese researchers present phase I data for JWCAR-029 in B-cell non-Hodgkin's lymphoma

ASH 2018: Multiple studies give new insights into clotting cascade

FDA clears IND for first-in-human trial of QR-421a in patients with Usher syndrome type 2

Novartis initiates phase III trials of ligelizumab for chronic spontaneous urticaria

Wakamoto announces Japanese phase III trial of WP-1303 for glaucoma and ocular hypertension

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...